The Lipid & Diabetes Monitoring Test is a comprehensive metabolic health screening package that includes 12 laboratory parameters to evaluate cholesterol levels, triglycerides, fasting blood sugar, and long-term glucose control.
The package combines a Lipid Profile (9 parameters) with a Diabetes Profile (3 parameters), including Total Cholesterol, HDL Cholesterol, LDL Cholesterol, Triglycerides, Non-HDL Cholesterol,
Fasting
Required
Report time
72–96 hours
Recommended for
Male & Female
Age group
18+ years
Tests
2 tests
Parameters
12 parameters
Parameters measured (9)
The Lipid & Diabetes Monitoring Test is a laboratory screening package designed to evaluate two important aspects of metabolic health: blood lipid levels and glucose regulation.
Also known as: Diabetes and Cholesterol Test, Lipid and Blood Sugar Profile, Diabetes Monitoring Package, Cholesterol and HbA1c Test, Metabolic Health Screening Package.
Diabetes and cholesterol abnormalities are important cardiovascular risk factors.
Individuals with diabetes may develop changes in lipid metabolism, including elevated triglycerides, low HDL cholesterol, and increased numbers of atherogenic lipoprotein particles.
These abnormalities may contribute to the development of atherosclerotic cardiovascular disease.
The Lipid & Diabetes Monitoring Test evaluates:
Together, these measurements provide information that healthcare professionals can use to evaluate metabolic health and monitor treatment.
However, the package does not directly assess insulin resistance, kidney function, or established cardiovascular disease.
The Lipid & Diabetes Monitoring Test may be suitable for:
It is a laboratory screening package containing 12 parameters that evaluate cholesterol, triglycerides, fasting blood glucose, HbA1c, and estimated average blood glucose.
The package includes 12 parameters across 2 test groups.
Yes. Fasting for 10–12 hours is required according to the package instructions.
Yes. Glycated Hemoglobin (HbA1c) is included.
| Package name | Lipid & Diabetes Monitoring Test |
|---|---|
| Location | Ajmer |
| Sample type | Blood |
| Number of tests | 2 |
| Number of parameters | 12 |
| Home sample collection | Available |
| Fasting | Fast for 10–12 hours before sample collection. Plain water is generally permitted. |
| Report time | 72–96 hours |
| Recommended age | 18+ years |
| Suitable for | Male & Female |
Parameters measured (3)
## What Is Included in the Lipid & Diabetes Monitoring Test?
### 1. HDL Cholesterol Direct
High-Density Lipoprotein (HDL) cholesterol is commonly called *good cholesterol*.
HDL particles participate in transporting cholesterol from tissues toward the liver.
Low HDL cholesterol may be associated with increased cardiovascular risk, particularly when accompanied by other metabolic abnormalities.
However, HDL cholesterol should not be interpreted independently of LDL cholesterol, triglycerides, and overall cardiovascular risk.
### 2. LDL Cholesterol – Calculated
Low-Density Lipoprotein (LDL) cholesterol is commonly called *bad cholesterol*.
Elevated LDL cholesterol contributes to plaque formation in arteries and increases the risk of atherosclerotic cardiovascular disease.
The package includes calculated LDL cholesterol, which is estimated using other lipid measurements.
Calculated LDL may be less accurate in certain situations, particularly when triglyceride levels are very high.
### 3. Total Cholesterol
Total cholesterol measures the overall amount of cholesterol circulating in the blood.
It includes cholesterol carried by different lipoprotein particles.
Elevated total cholesterol may be associated with increased cardiovascular risk, although interpretation requires consideration of LDL, HDL, and other risk factors.
### 4. Triglycerides
Triglycerides are a type of fat used for energy storage.
Elevated triglycerides may occur in individuals with:
Very high triglyceride levels can increase the risk of pancreatitis.
### 5. VLDL
Very Low-Density Lipoprotein (VLDL) carries triglycerides through the bloodstream.
VLDL is often estimated from triglyceride measurements.
Elevated triglyceride-rich lipoproteins may contribute to cardiovascular risk.
### 6. Non-HDL Cholesterol
Non-HDL cholesterol represents cholesterol carried by lipoproteins other than HDL.
It includes LDL and other potentially atherogenic lipoproteins.
Non-HDL cholesterol is a useful measurement for cardiovascular risk assessment, particularly in individuals with elevated triglycerides or diabetes.
### 7. LDL/HDL Ratio
The LDL/HDL ratio compares LDL cholesterol with HDL cholesterol.
It may provide supplementary information about lipid balance.
However, cardiovascular treatment decisions generally prioritize LDL cholesterol, non-HDL cholesterol, and overall risk rather than ratios alone.
### 8. HDL/LDL Cholesterol Ratio
The HDL/LDL ratio compares HDL cholesterol with LDL cholesterol.
It is mathematically related to the LDL/HDL ratio.
Although it may be included in laboratory reports, it is not generally used as a primary treatment target.
### 9. Cholesterol/HDL Ratio
The total cholesterol-to-HDL ratio compares total cholesterol with HDL cholesterol.
It may provide additional information about cardiovascular risk.
The result should be interpreted alongside other lipid measurements and individual risk factors.
### 10. Glycated Hemoglobin (HbA1c)
HbA1c reflects average blood glucose levels over approximately two to three months.
It is commonly used to:
HbA1c results may be affected by certain conditions involving red blood cells, hemoglobin variants, or altered red blood cell turnover.
### 11. Fasting Blood Glucose
Fasting glucose measures blood sugar after an overnight fast.
It may help identify normal glucose regulation, prediabetes, or diabetes.
Fasting glucose provides information about blood sugar at the time of testing, whereas HbA1c reflects longer-term glucose exposure.
### 12. Average Blood Glucose
Estimated average blood glucose is generally calculated from HbA1c.
It provides an approximate representation of average blood sugar levels over the preceding two to three months.
It is not a separate direct measurement of blood glucose.
## Why Is the Lipid & Diabetes Monitoring Test Done?
Healthcare professionals may recommend this package to:
## Benefits of the Lipid & Diabetes Monitoring Test
## Preparation Before the Test
The Lipid & Diabetes Monitoring Test requires a blood sample.
Do not stop prescribed medication without medical advice.
## Healthy Tips for Managing Cholesterol and Blood Sugar
## Who Should Book This Package?
The Lipid & Diabetes Monitoring Test may be suitable for:
Note: The package does not include kidney function tests, urine albumin-to-creatinine ratio, or other investigations commonly recommended during comprehensive diabetes care.
Note: The package does not include kidney function tests, urine albumin-to-creatinine ratio, or other investigations commonly recommended during comprehensive diabetes care.
Yes. Fasting glucose is included.
HbA1c reflects average blood sugar over approximately two to three months, while fasting glucose measures blood sugar at the time of testing after fasting.
Fasting glucose and HbA1c may support diabetes diagnosis when established diagnostic criteria are met. Confirmation may be required depending on clinical circumstances.
Yes. HbA1c and fasting glucose may identify results within the prediabetes range.
Yes. It includes nine lipid-related parameters.
Yes. Calculated LDL cholesterol is included.
Yes. Direct HDL cholesterol is included.
Yes. Serum triglycerides are included.
Yes. VLDL is included.
Yes. Non-HDL cholesterol is included.
Diabetes is associated with increased cardiovascular risk, and cholesterol management is an important part of reducing that risk.
Insulin resistance and diabetes may be associated with elevated triglycerides, low HDL cholesterol, and other lipid abnormalities.
Yes. Appropriate nutrition, physical activity, weight management when indicated, and prescribed treatment can improve glucose control.
Yes. Dietary changes, regular physical activity, and weight management when appropriate can improve certain cholesterol and triglyceride measurements.
No. Fasting insulin is not included.
No. HOMA-IR is not included.
No. Kidney function tests are not included.
No. Lipid measurements help evaluate cardiovascular risk but cannot independently diagnose coronary artery disease or other heart conditions.
No. Normal laboratory results do not rule out all metabolic or cardiovascular conditions.
Home blood sample collection may be available through OnHealth in supported locations, subject to partner laboratory availability.
Report turnaround time depends on the partner laboratory. Confirm the expected reporting time when booking.
Testing frequency depends on diabetes status, treatment, previous results, cardiovascular risk, and clinical recommendations. HbA1c may be checked approximately every three months when treatment is changing or glucose targets are not met, and less frequently when control is stable. Lipid testing frequency is individualized.